# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elisabeth of Austria (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI030-SYN-TD
- Date: 1894-03-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adelheid Marchetti-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Empress Elisabeth is a 56-year-old woman with anorexia nervosa, restricting type, in outpatient treatment, and recurrent depression, who comes for a preventive visit between her eating disorder reviews. She has followed most of the meal plan, with her dietitian's help by video while she was away for ten days. She walks for about an hour a day and has not used the gymnastics apparatus. She started sertraline 25 mg three weeks ago and increased to 50 mg a week ago, with mild nausea for two days. She still has passive thoughts of being better off dead on some days, less often, with no intent or plan; she keeps her safety plan with her. She stopped having periods in her late forties. She asked that this visit not be used to weigh her in front of anyone. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 56 |
| Eating disorder | Following most of the meal plan; walks about an hour a day |
| Sertraline | 50 mg for a week; mild nausea for two days |
| Mood | PHQ-9 13; passive thoughts less often; no intent or plan |
| Menopause | Last period in her late forties |

## Health risk assessment

Completed by the patient on paper in a private room and reviewed with her face to face by Dr. Marchetti-Osei. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair; less dizzy than before |
| Psychosocial | Low mood and grief; supportive companion; dislikes public attention |
| Tobacco | Never |
| Alcohol | None |
| Physical activity | Walks about an hour a day, limited by the treatment plan |
| Nutrition | Three meals and two snacks on the dietitian's plan |
| Sleep | Six hours, broken |
| Sexual health | No concerns raised |
| Safety | Feels faint less often; no falls; walks alone on country roads |
| Road safety | Wears a seat belt; does not drive |
| Activities of daily living | Independent |
| Hearing and vision | Normal by her report |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Less tired; cold hands |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No dental pain |
| Cardiovascular | Negative | No palpitations or fainting; ankle swelling gone |
| Respiratory | Negative | No cough |
| Gastrointestinal | Positive | Fullness after meals; no vomiting; bowels regular |
| Genitourinary | Negative | No urinary symptoms; no postmenopausal bleeding |
| Musculoskeletal | Negative | No bone pain or fractures |
| Integumentary | Positive | Dry skin; fine hair on the arms |
| Neurological | Negative | Dizziness on standing much less |
| Psychiatric | Positive | Low mood and grief; PHQ-9 13 |

11 systems reviewed. **S**

## Current medications

- Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily **S**
- Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 100/64 mmHg; pulse 58 bpm; respirations 14/min; temperature 36.3 °C; oxygen saturation 98% on room air; weight 50.4 kg; BMI 17 kg/m². All vital signs are synthetic.

PHQ-9: 13. All results are synthetic.

## Change since baseline

- PHQ-9: 16 at baseline, 13 at this visit **S**

## Immunizations given today

- Recombinant zoster vaccine, dose 1 of 2 **S**
- Pneumococcal conjugate vaccine (PCV20) **S**
- Tdap vaccine **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin; weight 50.4 kg, BMI 17.0; blood pressure 100/64, pulse 58, temperature 36.3 C |
| Head, eyes, ears, nose, and throat | No parotid swelling; dental enamel intact |
| Breasts | No masses or skin changes |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Abdomen | Scaphoid, soft, non-tender |
| Skin | Dry skin, fine lanugo-like hair on the forearms; no lesions of concern |
| Psychiatric | Guarded, mood low, affect constricted; no intent or plan to harm herself |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan made. Recombinant zoster vaccine dose 1, PCV20 and Tdap given. Mammography, cervical screening, colorectal screening by stool test, and HIV, hepatitis C and hepatitis B screening ordered. Bone density measured three weeks ago. Lipid screening deferred until weight is restored, because starvation distorts the result. **S**
   - Second zoster vaccine dose in two to six months.
   - Mammogram and cervical screening booked at the women's health clinic, in a private appointment.
   - Next preventive visit in one year.
2. **Anorexia nervosa, restricting type** (F50.011). Weight 50.4 kg, BMI 17.0, gaining; pulse 58. **S**
   - Continue the team plan; next eating disorder review as booked.
3. **Recurrent depression with persistent grief** (F33.1). PHQ-9 13, early on sertraline 50 mg; passive thoughts less often, no intent or plan. **S**
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
   - Continue sertraline 50 mg.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 100/64 mmHg |
| Depression screening | Completed today | PHQ-9 13 on treatment; followed in her depression care |
| Tobacco use | Completed today | Never used tobacco |
| Unhealthy alcohol use | Completed today | No alcohol |
| Breast cancer screening | Ordered | Biennial mammography from 40 to 74; ordered |
| Cervical cancer screening | Ordered | HPV testing every five years from 30 to 65; no record of recent screening; ordered |
| Colorectal cancer screening | Ordered | Due from 45; she chose a yearly fecal immunochemical test; kit given |
| Osteoporosis screening | Up to date | DXA three weeks ago for a postmenopausal woman under 65 at increased risk: low bone mass |
| Cholesterol and cardiovascular risk | Due | Due; postponed until weight is restored, because starvation can raise cholesterol; to be checked at the next preventive visit |
| Diabetes screening | Not indicated | Not overweight; glucose followed in her eating disorder care |
| HIV screening | Ordered | One-time screening for adults 15 to 65; drawn today with her agreement |
| Hepatitis C screening | Ordered | One-time antibody test for adults 18 to 79; drawn today |
| Hepatitis B screening | Ordered | One-time triple panel drawn today |
| Zoster vaccine | Completed today | Recombinant zoster vaccine dose 1 of 2 today |
| Pneumococcal vaccine | Completed today | PCV20 today; recommended for all adults 50 or older |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today |
| Influenza vaccine | Due | In the autumn |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent, because she travels for long periods and has a serious illness. She named a health care agent and a second agent, and a health care proxy form was completed; both are recorded in the restricted chart and are not named here. She wants full treatment of any medical complication, including hospital care for her eating disorder if her team advises it, and she agreed that the team may share information with her agent if she is too unwell to decide. The plan will be revisited in a year or sooner if her health changes. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023), American Psychiatric Association (American Journal of Psychiatry 2023;180(2):167-171)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Twelve-week eating disorder review in five weeks. Screening results through the patient portal, which is set to private. **S**
- Next scheduled visit 1894-04-28: twelve-week review: weight restoration, exercise, mood and sertraline. **S**
